Bleakley Financial Group LLC bought a new position in shares of Ventas, Inc. (NYSE:VTR – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 11,703 shares of the real estate investment trust’s stock, valued at approximately $906,000.
Several other institutional investors and hedge funds have also bought and sold shares of the stock. PGGM Investments acquired a new position in shares of Ventas in the fourth quarter valued at approximately $98,686,000. Global Assets Advisory LLC grew its position in shares of Ventas by 13.5% in the fourth quarter. Global Assets Advisory LLC now owns 3,986 shares of the real estate investment trust’s stock valued at $308,000 after purchasing an additional 475 shares during the last quarter. Allstate Corp grew its position in shares of Ventas by 121.5% in the fourth quarter. Allstate Corp now owns 48,827 shares of the real estate investment trust’s stock valued at $3,778,000 after purchasing an additional 26,783 shares during the last quarter. Summitry LLC grew its position in Ventas by 10.9% during the fourth quarter. Summitry LLC now owns 4,280 shares of the real estate investment trust’s stock worth $331,000 after buying an additional 421 shares in the last quarter. Finally, Clearstead Advisors LLC grew its position in Ventas by 303.0% during the fourth quarter. Clearstead Advisors LLC now owns 6,025 shares of the real estate investment trust’s stock worth $466,000 after buying an additional 4,530 shares in the last quarter. Institutional investors own 94.18% of the company’s stock.
Insider Activity at Ventas
In other news, Director Walter C. Rakowich sold 1,152 shares of the business’s stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total transaction of $103,910.40. Following the completion of the transaction, the director directly owned 28,349 shares in the company, valued at $2,557,079.80. The trade was a 3.90% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is owned by company insiders.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Analysis on Ventas
Ventas Stock Down 1.4%
Ventas stock opened at $84.55 on Friday. Ventas, Inc. has a 1-year low of $61.76 and a 1-year high of $91.06. The firm has a market capitalization of $41.10 billion, a price-to-earnings ratio of 153.72, a P/E/G ratio of 1.89 and a beta of 0.74. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.95. The firm has a 50 day simple moving average of $85.30 and a 200 day simple moving average of $82.24.
Ventas (NYSE:VTR – Get Free Report) last released its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a net margin of 4.25% and a return on equity of 2.09%. The business had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter in the prior year, the firm posted $0.84 earnings per share. The firm’s quarterly revenue was up 22.0% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. On average, analysts predict that Ventas, Inc. will post 3.88 earnings per share for the current year.
Ventas Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date is Tuesday, June 30th. Ventas’s payout ratio is 378.18%.
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Featured Articles
- Five stocks we like better than Ventas
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
